ExpressCells
Signal active
Organization
Contact Information
Overview
ExpressCells is a biotechnology company that uses genetic engineering to create custom cell lines for biological research and drug discovery. The company's primary focus is on creating research tools that will speed drug discovery and provide better disease models for basic researchers.
ExpressCells was established by Oscar Perez-Leal and Matt Handel in 2018 and is headquartered in Philadelphia, Pennsylvania.
About
Industries
Biotechnology, Medical, Product Research
Founded
2018
Employees
1-10
Headquarters locations
Philadelphia, Pennsylvania, United States, North America
Social
Profile Resume
ExpressCells headquartered in United States, North America, operates in the Biotechnology, Medical, Product Research sector. The company focuses on Biotechnology and has secured $43.0M in funding across 24 round(s). With a team of 1-10 employees, ExpressCells is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - ExpressCells, raised $590.5K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
4
Lead Investors
0
Total Funding Amount
$1.8M
Details
1
ExpressCells has raised a total of $1.8M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2019 | Early Stage Venture | 1.2M |
Investors
ExpressCells is funded by 11 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Berkeley Angel Network | - | FUNDING ROUND - Berkeley Angel Network | 590.5K |
| MIT Alumni Angels of Northern California | - | FUNDING ROUND - MIT Alumni Angels of Northern California | 590.5K |
| ExpressCells | - | FUNDING ROUND - ExpressCells | 590.5K |
| Tech Coast Angels | - | FUNDING ROUND - Tech Coast Angels | 590.5K |
Recent Activity
News
Mar 15, 2024
The Business Journals - Temple gene editing spinout ExpressCells quietly ceases operations, sued by lender - Philadelphia Business Journal
News
Mar 15, 2024
Business Journals - Temple gene editing spinout ExpressCells quietly ceases operations, sued by lender
News
Mar 14, 2024
The Business Journals - Temple gene editing spinout ExpressCells quietly ceases operations, sued by lender - Philadelphia Business Journal
Funding Round
Oct 23, 2020
ExpressCells raised $590500 on 2020-10-23 in Venture Round
Funding Round
Jul 01, 2019
ExpressCells raised $1200000 on 2019-07-01 in Series A